Specialized Healthcare Focus Berry & Company’s proven expertise in public relations for pharma, life sciences, and medical device clients positions them as a valuable partner for organizations seeking targeted communication support in health-related sectors, especially around FDA approvals and clinical research.

Strong Industry Relationships With over 50% of clients retained for more than five years, the company demonstrates high client loyalty and satisfaction, indicating opportunities for expanding existing relationships or cross-selling additional strategic communications services.

Acquisition Growth Strategy Following their acquisition by CG Life and the strategic move to expand healthcare communications, there is an increased potential to leverage broader capabilities and resource networks for offerings in integrated health and biopharma marketing solutions.

Market Positioning Compared to larger competitors with extensive staff and revenues, Berry & Company’s niche focus and tailored approach could appeal to smaller or mid-sized biotech and pharmaceutical firms looking for specialized, cost-effective PR support.

Digital and Technology Stack Utilization of advanced tech such as HTTP/3, OpenResty, and cloud services highlights a modern approach; emphasizing their capability to implement innovative digital communication strategies could attract clients looking for cutting-edge PR and content distribution solutions.